Polat, N.Ozer, M. A.Parlakpinar, H.Vardi, N.Aksungur, Z.Ozhan, O.Yildiz, A.2024-08-042024-08-0420181052-02951473-7760https://doi.org/10.1080/10520295.2017.1406616https://hdl.handle.net/11616/98133We investigated the effect of molsidomine (MOL) on ischemia/reperfusion (I/R) injury. Rabbits were assigned to four groups: group 1, sham; group 2, I/R; group 3, MOL treatment for 4days after I/R; group 4, MOL treatment for 1 day before I/R and 3days after I/R. Retinal I/R was produced by elevating the intraocular pressure to 150mm Hg for 60min. Seven days after I/R, the eyes were enucleated. Retinal changes were examined using histochemistry. The levels of malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT) also were measured. We found a significant increase in the thickness of the outer nuclear layer of group 3 compared to the other groups. In groups 3 and 4, caspase-3 stained cells in the ganglion cell layer were decreased compared to group 2. We found a significant increase in caspase-3 stained cells in the inner nuclear layer (INL) of group 2 compared to the other groups. We found a significant increase in caspase-3 stained cells in group 3 compared to group 4 in the INL. The MDA level in group 2 was significantly higher than group 1 and MOL significantly decreased MDA levels in groups 3 and 4. We found that MOL protected the retina from I/R injury by enhancing antioxidative effects and inhibiting apoptosis of retinal cells.eninfo:eu-repo/semantics/closedAccessapoptosisischemiareperfusionmolsidomineoxidative stressrabbitretinaArticle9331881972932354310.1080/10520295.2017.14066162-s2.0-85040962319Q2WOS:000435663500004Q4